Dr. Miro is an accredited IDIBAPS researcher who has two research lines: 1) Infective endocarditis (including the experimental model), as Group leader (R4); and, HIV/AIDS (epidemiological studies in HIV cohorts, primary HIV-1 infection, tuberculosis and other opportunistic Infections, clinical trials in advanced patients and solid organ transplantation in HIV-1 infected patients), as R3A researcher. Dr. Miro has published 800 articles in peer-review journals (h-index 72).